Royal Bank of Canada
IPSC icon

Royal Bank of Canada’s Century Therapeutics IPSC Stock Holding History

Royal Bank of Canada’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Buy
4,394
+4,325
+6,268% +$9.09K ﹤0.01% 6205
2025
Q4 		$0 Sell
69
-2
-3% -$1 ﹤0.01% 7380
2025
Q3 		$0 Sell
71
-28
-28% -$15 ﹤0.01% 7307
2025
Q2 		$0 Sell
99
-5,792
-98% -$3.11K ﹤0.01% 7171
2025
Q1 		$3K Sell
5,891
-1,436
-20% -$1.08K ﹤0.01% 6491
2024
Q4 		$7K Buy
7,327
+1,943
+36% +$2.65K ﹤0.01% 6451
2024
Q3 		$9K Buy
5,384
+1,069
+25% +$2.09K ﹤0.01% 6361
2024
Q2 		$11K Buy
4,315
+2,842
+193% +$8.98K ﹤0.01% 6300
2024
Q1 		$6K Sell
1,473
-5,974
-80% -$25.3K ﹤0.01% 6383
2023
Q4 		$25K Buy
7,447
+3,151
+73% +$5.74K ﹤0.01% 6244
2023
Q3 		$9K Buy
4,296
+1,305
+44% +$3.47K ﹤0.01% 6454
2023
Q2 		$10K Buy
2,991
+1,457
+95% +$4.7K ﹤0.01% 6474
2023
Q1 		$5K Sell
1,534
-1,423
-48% -$6.25K ﹤0.01% 6569
2022
Q4 		$15K Buy
2,957
+2,711
+1,102% +$25.6K ﹤0.01% 6402
2022
Q3 		$2K Buy
246
+132
+116% +$1.39K ﹤0.01% 7027
2022
Q2 		$1K Sell
114
-951
-89% -$9.33K ﹤0.01% 7138
2022
Q1 		$13K Sell
1,065
-1,683
-61% -$22.3K ﹤0.01% 6833
2021
Q4 		$43K Buy
2,748
+1,349
+96% +$25.3K ﹤0.01% 6449
2021
Q3 		$35K Buy
+1,399
New +$37.9K ﹤0.01% 6364

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Royal Bank of Canada's IPSC Position: Q1 2026 in Review

Royal Bank of Canada increased its Century Therapeutics (IPSC) stake by 6,268% in Q1 2026, buying an estimated $9.09K and bringing the position to 4,394 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #6205.

Royal Bank of Canada first reported a position in IPSC in Q3 2021 and has held it in 19 quarters since. The position peaked at $43K in Q4 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Royal Bank of Canada held 4,394 shares of Century Therapeutics worth $9K as of Q1 2026.
  • Royal Bank of Canada bought 4,325 Century Therapeutics shares in Q1 2026, an estimated $9.09K.
  • Century Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6205 holding.
  • Royal Bank of Canada first reported a position in Century Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Century Therapeutics position peaked at $43K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.